---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-097776"
form_type: "8-K"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2024-04-16T23:59:59+00:00"
generated_at: "2026-06-03T22:04:10.936092+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CareDx appoints John W. Hanna as President and CEO effective April 15, 2024

## Summary
- John Hanna appointed CEO and Class III director, effective April 15, 2024.
- Annual base salary of $675,000; eligible for annual bonus up to 100% of salary.
- Received inducement options and RSUs each valued at $4M, vesting over four years.
- Previously CEO of Apton Biosystems and CCO at Veracyte for ten years.

## SEC filing metadata
- accession: 0001193125-24-097776
- form_type: 8-K
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2024-04-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/d822701d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-097776
- JSON: https://secwatch.observer/filing/0001193125-24-097776.json
- Plain text: https://secwatch.observer/filing/0001193125-24-097776.txt

## Key facts
- Executive change
  John W. Hanna was appointed as Class III director at CareDx, Inc..
  - Action: appointed
  - Role: Class III director
  source text: The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm
- Executive change
  John W. Hanna was appointed as President and Chief Executive Officer at CareDx, Inc..
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: The Board of Directors (the “Board”) of CareDx, Inc. (the “Company”) has appointed John W. Hanna as the Company’s President and Chief Executive Officer and as a Class III director of the Company, in each case effective April 15, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1217234/000119312524097776/0001193125-24-097776-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.